Leidos Holdings Inc (LDOS) — Q1 2021 Earnings Call Transcript

Thank you, and good morning, everyone. I’d like to welcome you to our first quarter 2021 earnings conference call. Joining me today are Roger Krone, our Chairman and CEO; Jim Reagan, our Chief Financial Officer; and other members of the Leidos management team. Today, we will discuss our results for the quarter ending April 2, 2021. Roger will lead off the call with notable highlights from the quarter, as well as comments on the market environment and our Company's strategy. Jim will follow with a discussion of our financial performance and our guidance expectations. After these remarks from Roger and Jim, we’ll open the call for your questions. Today's discussion contains forward-looking statements based on the environment as we currently see it, and as such does include risks and uncertainties. Please refer to our press release for more information on the specific risk factors that could cause actual results to differ materially. Finally, during the call, we will discuss GAAP and non-GAAP financial measures. A reconciliation between the two is included in the press release that we issued this morning and is also available in the presentation slides. The press release and presentation, as well as a supplementary financial information file, are provided on the Investor Relations section of our website at ir.leidos.com. With that, I’ll turn the call over to Roger Krone.

Thank you, Peter, and thank you all for joining us this morning for our first quarter 2021 earnings conference call. As we communicated in our press release this morning, I'm pleased to announce that Chris Cage will be Leidos' next Chief Financial Officer later this year. Chris will succeed Jim Reagan who has chosen to retire following a long and distinguished career, in particular, the last six years as my good friend and business partner. I will have a few remarks on this transition before I hand the call over to Jim, but first let's jump into the quarter. First quarter results reflect the perseverance, focus, and tremendous execution of our employees and business partners. New quarterly record levels of revenue, non-GAAP EPS, and backlog were achieved, and significant organic growth was delivered across all business segments. This early momentum favorably positions Leidos to deliver on our full-year financial commitments. Revenues for the quarter were $3.3 billion, up 14.7% from the prior year, and up 9% organically, underscoring our accelerated recovery from last year's pandemic headwinds and the early ramp of new business wins. Adjusted EBITDA margin of 11.7%, up 240 basis points compared to the prior year period reflects strong program performance and the resolution of the long-standing MSA legal matter, which together delivered 45% growth on non-GAAP EPS of $1.73 for the quarter. Net bookings of $3.8 billion resulted in a book-to-bill of 1.2 times and 1.3 times on a trailing 12-month basis. This increase, driven by success in both our Solutions and Health segments, established a record backlog of $32.6 billion for a 13th consecutive quarter, providing greater clarity and confidence in near-term revenue growth expectations. I will now touch on a few of the major wins we received in the quarter that underpin our growth and backlog. In the Health segment, the company was awarded a new prime contract to provide non-medical counseling to military service members and their families through the Military & Family Life Counseling program known as MFLC. This important work will be conducted at approximately 100 U.S. military installations or nearby civilian communities. We currently estimate revenues will be approximately $1 billion over the potential seven-year life of the program. This new award is especially timely with May being mental health awareness month. Military members and their families experience unique stresses. These include fears for the safety of the service member and feeling anxious or overwhelmed by deployment-related challenges and responsibilities. Nearly one in four active-duty service members show signs of a mental health condition. Children of service members are especially vulnerable. One third of children with a deployed parent have psychological challenges, such as depression, anxiety, and behavior disorders. Through our work on the MFLC program, we provide confidential counseling to alleviate stresses and enhance military members and their families' ability to cope with these challenges. Counselors aim to prevent the escalation of stress into harmful conditions. About a quarter of our employees are veterans, so this program is meaningful to us on many levels. Next, in the Civil segment, the company was awarded a prime contract by U.S. Customs and Border Protection to provide multi-energy portal systems for non-intrusive inspection of commercial vehicles at land and sea ports of entry. Under the contract, Leidos will integrate, deploy, and train CBP staff to use its VACIS MEP with low-energy backscatter and high-energy transmission cargo inspection system. The multiple award IDIQ contract has a total value of $480 million and a five-year base period of performance with options up to 10 years if exercised. And in the Defense Solutions segment, the company was awarded a prime contract by the Naval Undersea Warfare Center to provide engineering, technical, and management services for the Naval Array Technical Support Center. Leidos will be responsible for production engineering, technical, and logistics support of the U.S. Navy and foreign governments towed array assets. This single award IDIQ contract has a total estimated value of $149 million. Finally, the company was awarded contracts valued at $822 million if all options are exercised by U.S. National Security and Intelligence clients. Though the specific nature of many of these contracts is classified, they all encompass mission-critical services that help to counter global threats and strengthen national security. Turning now to several notable accomplishments and events that took place in the quarter. We closed the 1901 Group acquisition in January and as anticipated, the business is being levered across all of our business segments in both the performance of backlog programs and new program bids. The inclusion of 1901 Group's cloud-based solutions and fully integrated service delivery platform will enhance performance on our customers' important missions and continue to differentiate Leidos' value proposition across the defense, intelligence, civil, and health markets we serve. Furthermore, as we shared with you on the February call, the Gibbs & Cox acquisition is nearing completion with yesterday's expiration of the HSR waiting period. With that gate cleared, we now expect the deal to close later this month. Also, I want to take a moment to highlight the ongoing significant progress with the DoD Healthcare Management Systems Modernization program, otherwise known as DHMSM. The MHS GENESIS electronic health record system is now 30% deployed and is currently live and operational at more than 42 military treatment facility commands across the country with nearly 41,000 active users. Notably, during this unprecedented global healthcare crisis, this system has provided advanced capabilities to support clinicians and advice and providers, including 24/7 access to medical and dental records and effectively tracking COVID-19 cases and mass vaccinations. Since its initial award, the program has been expanded to include the United States Coast Guard and the National Guard and Reserve. We remain on schedule to deliver MHS GENESIS by the end of calendar year 2023. Shifting to the macro environment, while we are still awaiting the release of the President's 2022 Detailed Budget Request and subsequent multiyear defense projections, we are encouraged by last month's release of the high-level budget request. While the recommended defense funding level was in line with our expectations, our innovative technology and strategic investments remained squarely aligned with the administration's prioritization of certain critical need areas, such as digital modernization, cybersecurity, autonomy, and hypersonics. Additionally, we are very pleased with the proposed 16% increase in non-defense discretionary funding. This proposed growth supports the value proposition of our diverse business portfolio, which extends beyond defense and intelligence into the federal health and civil markets, including ports, borders, and airport security. And while a continuing resolution in the fall is feeling like a near certainty, the typical annual disruptions may be muted given the no growth request for defense and the reality that under a CR, agencies generally continue to receive stopgap funding in line with prior years' appropriation levels. With nearly $6 trillion of congressionally approved relief and stimulus funding since the start of the pandemic and a pending $2 trillion infrastructure request, we believe there could be additional opportunities for Leidos, particularly in our Civil segment. Areas of interest include airport and FAA upgrades, as well as civil agency research and development. However, we will need to see the final details when they become available to better understand what is truly addressable over the multiyear infrastructure plan. With regard to the administration's decision to withdraw all troops from Afghanistan by early September, Leidos has been directed to leave the region within the same timeline. We currently estimate the revenue impact to be less than 1% of our Defense Solutions segment's current year revenue. While program-level customer discussions are still evolving, our best estimates have been incorporated into the guidance that Jim will cover later in the call. As we recently marked the one-year milestone of this devastating pandemic at the end of Q1, I want to provide you with another update on our Leidos Relief Foundation and how it has been assisting Leidos employees who have been impacted by the virus. Since March 2020, the fund has raised and distributed over $1.7 million through generous personal donations from employees, members of the executive team, and the Board of Directors, including company matched contributions. With those funds, over 500 Leidos families who have suffered a COVID-19 hardship or loss of a loved one have received financial assistance. The ongoing generosity of our colleagues is inspiring and a constant reminder of our shared values no matter the challenge. Finally, as I noted at the top of the call, I will close my prepared remarks with a few comments on the upcoming CFO transition here at Leidos. On behalf of our Board of Directors and management team, I want to thank Jim for his countless contributions to this company and wish him all the best in his planned retirement. Jim joined us six years ago and has been my steadfast advisor and business partner. Jim and his team have grown the business over 160%, built an investment-grade balance sheet, and delivered significant total shareholder return. While Jim's contributions were critical in strategic planning and M&A deal structuring for key transactions, value creation takes place in successful business transformations and building and nurturing culture and talent, and that is where Jim made the biggest impact for our employees, customers, and shareholders. Thank you, Jim. However, I will save my goodbye since you'll be continuing to be an advisor through year-end. Meanwhile, I'm pleased to share that our Board of Directors has elected Chris Cage as our next Chief Financial Officer effective July 5 of this year, the beginning of our third quarter. Chris is a great example of the talent development and succession planning process here at Leidos. Chris joined the company in 1999 and many of you have had a chance to interact with him over the last several years as he has held a series of financial leadership roles with increasing responsibility, most recently as our Chief Accounting Officer. His financial experience and deep understanding of our business have prepared him and therefore our company for continued success. Since it is May 4, before I turn the call over to Jim, I just wanted to say May 4th be with you. I will now turn the call over to Jim Reagan for more details on our first quarter results and guidance.

Thank you, Roger for those kind words and thanks to everyone for joining us on the call today. Upon reflection, I've had a very fulfilling career and these past six years here at Leidos have been truly special on account of all of the passionate and brilliant people who work here. I deeply value the relationships that we've built and the accomplishments that we have achieved together. I have great confidence in Chris's ability to lead the finance organization and I look forward to working with him on a seamless transition. With that, I'll start by providing an overview of our first quarter 2021 results, followed by an update to the 2021 guidance. We are pleased with our strong start and growth momentum through the first quarter of 2021. First quarter revenue grew 14.7% over the prior year quarter and 8.9% organically. The increase in revenue was driven by the Dynetics SD&A and 1901 Group acquisitions, growing on our existing programs, and increased contribution from new programs. This solid start to the year aligns with our fourth-quarter messaging and showcases our resilient program execution fundamentals with all segments delivering double-digit top-line growth. Adjusted EBITDA margins of 11.7% grew 240 basis points over the prior year quarter. The increase was driven by program performance, mix, and continued indirect cost management, as well as the benefit from the successful settlement of the MSA legal matter. Excluding the positive impact of this $26 million legal reserve adjustment, adjusted EBITDA margins would have been approximately 11%. First quarter non-GAAP diluted EPS of $1.73 grew $0.54 over the prior year quarter, driven by strong execution and organic growth, as well as the settlement of the MSA legal matter. Without the settlement, non-GAAP diluted EPS would have been $1.59 reflecting 34% growth year-over-year. Operating cash flows for the quarter were $239 million. Excluding the net proceeds from the accounts receivable monetization facility, operating cash flows would have been approximately $145 million. The decision to utilize the facility enabled us to buy back approximately $100 million of Leidos stock on the open market during the quarter, which aligns with our long-term balanced capital allocation strategy. This consists of being appropriately levered and maintaining our investment-grade rating, and returning a quarterly dividend to our shareholders, reinvesting for growth, both organically and inorganically and returning excess cash to shareholders in a tax-efficient manner. Additionally, first quarter operating cash flow does not reflect any net cash benefit from the MSA settlement, which is expected to be realized in the second quarter. Bookings of $3.8 billion were strong across all segments, resulting in a 1.2 times consolidated book-to-bill and record ending backlog of $32.6 billion. This represents 15% growth in backlog from the first quarter of 2020. Now for an overview of our segment results. Defense Solutions revenue increased 14.8% year-over-year and 9.2% organically. Driving the strong growth was the Dynetics acquisition, the diligent execution of new programs, such as the CBP Traveler Processing and Vetting Software system, and growth on existing programs. As a reminder, consistent with our policy, Dynetics revenue will now be included in our organic revenue calculation since we owned the business for a full year effective February 2021. Defense Solutions non-GAAP operating margins of 9.2% increased 240 basis points from the prior year period, reflecting strong program growth on certain contracts, reduced indirect expenditures, and the recovery of a previously reserved international receivable. Defense Solutions booked nearly $2 billion in net awards for the quarter, resulting in a book-to-bill of 1.0x and 1.3x on a trailing 12-month basis. In our Civil segment, revenues grew 17.1% from the prior year quarter and 6.1% organically. This growth was driven by the SD&A acquisition and volume growth on our existing programs. Non-GAAP operating margins in the Civil segment grew 110 basis points year-over-year, driven by the net benefit from the MSA legal reserve adjustment, partially offset by lower margins on certain programs. Civil recorded approximately $700 million in net bookings for the quarter, resulting in a 0.9 times book-to-bill and 1.1 times on a trailing 12-month basis. And finally, turning to our Health segment. Health segment revenues increased 11.5% over the prior year quarter on both a gross and organic basis. This growth was driven by increased volumes on existing programs, including the continued backlog burn down in our medical exam business and timing of wave deployments on the DHMSM contract. Health segment non-GAAP operating margins were strong at 18.6%, an increase of 310 basis points over the prior year quarter, reflecting increased volume and growth on programs with our VA and DoD customers, and reduced business investments into a commercial IT venture. We expect elevated levels of non-GAAP operating margin to continue through the first half of 2021 and return to normalized segment levels starting in the third quarter. The Health segment booked over $1.2 billion net awards driven by the successful win of the Military & Family Life Counseling contract, which resulted in a book-to-bill of 2.1 times for the quarter and 1.6 on a trailing 12-month basis. Before I turn to guidance, I want to give you a quick update on the $7.7 billion Navy Engine program. Transition and onboarding are going well, but due to the late fourth quarter resolution in the courts, the pace of the ramp was lighter than the first quarter. We expect the ramp to pick up considerably over the next two quarters, giving us confidence in the organic contribution in both this year and next, as outlined in last quarter's earnings call. Moving now to the remainder of the year. We are increasing our guidance for adjusted EBITDA margin, non-GAAP EPS, and operating cash flow to account for two distinct items, the settlement of the MSA legal matter and reduced share count resulting from our share repurchase during the quarter. Our guidance does not reflect the announced acquisition of Gibbs & Cox. As we've done in the past, we will provide an update in our next quarterly earnings call after the deal has closed. Our guidance range for revenue remains unchanged. We expect to deliver between $13.7 billion and $14.1 billion revenue for the year. We expect adjusted EBITDA margins for the year between 10.5% and 10.7%, a 20 basis point increase at the midpoint from the previous guidance, reflecting the benefit from the MSA legal matter. As a result of the $100 million share repurchase executed in the first quarter and the net gain from the MSA legal matter, we are increasing our non-GAAP EPS guidance by $0.20 to a range of $6.35 to $6.65 on the basis of 143 million shares outstanding. And finally, to account for the expected net proceeds from the MSA legal matter, we are increasing our operating cash flow guidance by $25 million to at or above $875 million for the year. This updated guidance assumes no full-year contribution from the accounts receivable monetization facility. And with that, I'll turn the call over to Rob so we can take some questions. Thank you.

Thank you very much. Good morning, Roger and Jim, congratulations on your retirement.

Good morning, Sheila.

Good morning. Maybe just because you spent a few minutes on your prepared remarks talking about this, Roger, and obviously, there's an acquisition this morning from one of your competitors, can you talk about your Health Division? How do you expect revenue growth to kind of work through within some 30% implemented at the moment or deployed? And just bigger picture in terms of the Health market, how do you see it evolving, whether the growth or just competitive nature of it?

Well, let's see, on DHMSM we will be at our current revenue level or higher for another couple of years. And Sheila, as you know, our Health Group has traditionally been our highest margin and our highest growth area and it's not surprising to us that others have seen the market as attractive as we have. And the interesting thing about the Health market is, it's always been highly competitive, and whether it's one of our competitors getting into one of our traditional businesses, it's just changing the name of the competitor. And it is a very much a commercial world and now we see the Biden Administration, maybe the Human Infrastructure Bill as it comes to pass, is continuing to increase the spend. And we think it raises the importance of agencies like CMS and Social Security. And that's going to attract maybe some new competitors and maybe some non-traditional competitors, which in our strategic view of the market, we have always expected. And we believe we are successful in that market because we offer value-added service to our customers and we are, if you will, sharpening our tools and getting ready for what we think will be a significant growth in the top line in the market overall.

Thank you.

Hi, good morning, and congrats Jim, best wishes ahead.

Thanks, Rob.

On the defense margins, they were sequentially up and above the level you had achieved previously in any quarter last year. So, I wanted to talk a little bit more about the drivers, you did touch on them, you talked about mix, etc., but and just whether COVID related margin pressure is easing there and if you can quantify the impact of the international receivable there?

Yes, starting with the last point, we anticipate the recovery on the international receivable to be around $2 million or $3 million. More fundamentally, the businesses have performed well in terms of execution. Companies with portfolios of our size usually have a program or two that don’t meet their expected margins, but the Defense Group has been executing well, particularly in managing indirect costs, which has positively impacted performance. That said, we did underspend our R&D budget slightly in the fourth quarter, and we expect R&D spending to increase through the rest of the year. This is crucial for our long-term strategic goals that will drive the business's growth. Lastly, regarding defense margins for the remainder of the year, they will remain strong, but I wouldn’t expect to see the Q1 margin level in every quarter for the rest of the year.

Jim, is that the case in all three segments you touched on this earlier that the second half is just a little bit lighter because the first quarter or first half was elevated, is that all three segments?

Well, you know, in Health we've got the backlog burn down that we talked about that because of the way the operating leverage in that segment works, the margins are going to be a little higher than normal through the second quarter of the year. Those margins will damp down a bit in the backend. But unless we find that healthcare costs are lower than we expect and if we find that our ability to generate proposals is more efficient somehow than we are currently modeling, I think that you could expect the margins to be a little bit lower in the back end of the year and that is across the board, yes.

Yes. Thank you very much.

Sure.

Thank you very much. So, could you comment a little bit on the burn off of the backlog of the medical exams in the Health area and what that means going forward? And then somewhat relatedly, Roger, you talk of the 16% increase in FY '22 Fed Civil budget. Talk about the opportunities you see there? Thanks so much.

Yes, let me start with the backlog. So, just for everyone on the line, we do medical exams for those people who are looking for disability benefits. Our largest customer is the VA, but we do them across the board. And during COVID there was a period of time we were shut down and a period of time that our efficiency was diminished because of social distancing, and so there was an inventory or backlog of people who want these exams. And it grew up pretty much through last year to really for us, an all-time high. Our commitment has been to work literally nights and weekends to overstaff our clinics to work off the backlog. And we're benefiting in this quarter by that although we did have some weather in Texas and other states that dampened our quarter down just a little bit. But we think it will take us into the third quarter before we get back to our normal run rate. That's our best estimate today Cai and we look at that level. The team looks at it every day. I look at it. Jim and I look at it on a weekly basis. We look at it by region and by type of exam. But we're making good progress. The backlog is significant, and we think it's probably going to affect third quarter as well. And this is all positive by the way as it was severely negative a year ago and we talked through that a year ago. As we think about the increase in the budget and about all we know at this point Cai, is what agencies look like they're getting the increase and we are all waiting for the PB to come out. But it does look like these are agencies for which we have a significant presence and significant heritage contract. So, it's civil infrastructure, it's also some health. I mentioned in my prepared remarks there's going to be ports and borders and airports, FAA infrastructure, those seem to be prime. There's probably going to be some roads and bridges, which is not really all that relevant to us. We think there may be some smart cities, smart highways, and we do have some contracts with the Department of Transportation, so we may benefit there. But the details are yet to be revealed and when we are on the call next quarter, we will have the budget and we will be able to address those better then, but thanks for your question Cai.

Thank you.

Hey, good morning.

Good morning.

Good morning, Gavin.

Congrats to both Jim and Chris.

Thank you.

I wanted to follow up on Cai's question. The initial request number of 16% often gets revised, but there seems to be more interest in Washington for increasing non-defense budgets compared to the last two years. So, what are your thoughts on whether that growth rate in the mid-teens or even double-digits is realistic and what the request messages are for the multiyear defense budget outlook?

Yes, Gavin it's really hard to handicap the most watched sport in the national capital region which is our political process. Yes, I think they're going to go to conference. I don't think they're going to try reconciliation, but they could. And if Central Mansion from West Virginia, who has some influence, I think they'll come down a little bit and defense may go up. There are some politicians that we talked to who say it's, assume it's sequester and it's a tit for tat. So, if you're going to take Civil up, you have to take Defense up. I don't think that's exactly where we're going to land. I think we're probably going to have a higher growth number on Civil than Defense. And by the way the Defense number, depending upon where you call it, 704, 715 or 753, does include the pay raise and now all go in the base budget. So if you look at it from that standpoint, the overall you could say has some downward pressure. The areas that we compete we view as just generally flat. We are though, I think when the dust settles and we get through this year and we get a bill, are expecting maybe high single or low double-digit increase on the Civil side. And that's going to benefit our Health and our Civil Group. We've already, as you would expect, put teams together to try to anticipate where those funds are going to be spent, and to make sure that we're doing the prep work to get ready to provide customers value on programs that they're going to come forward with. We actually think cybersecurity is a good area for us. We think DHS is what's called the CISA, which is their cybersecurity office which tends to deal with cybersecurity in the dot com space. We expect them both to get money in the base bill and money in the infrastructure bill. So, cybersecurity overall looks like a good place to be. Thanks, Gavin.

Thank you. Over the last handful of years or so, customers have been a little bit more willing to contract using different methods that end up being more profitable for service providers. What's your expectation for sort of a flattening of the defense budgets, meaning for the ability of that trend to continue in yield, good profit margins for the space?

Yes, let me address your comment and then I will let Jim add to it. We tend to perform better when contracts are either fixed price or time and materials, where the risk of performance is on us. This allows us to invest in initiatives like RPAs to drive more efficiency. We have what we call a cost-based contract, which limits our earnings potential based on the fees we bid. With fixed price contracts, we are almost immediately rewarded for technological innovations. It's difficult to identify trends, especially since not all officials in the Biden Administration have been confirmed. I wouldn’t say there’s a noticeable trend away from time and materials contracts. Initially, I thought you might bring up OTAs, which are still active, and I don’t foresee that changing. Ideally, I would prefer customers to shift towards more fixed price contracts, as they stabilize their costs and mitigate concerns over year-over-year expenses. This approach also gives us performance responsibility, allowing us to potentially earn more throughout the program’s duration if we can enhance efficiency. Jim, do you have anything to add?

Yes, just to pile on that, that also delivers a benefit for the customer because when we have more latitude in how to deliver a solution as opposed to something that's prescribed in a cost-type contract, it allows us to help the customer save some money too.

And if you could just provide a little bit more commentary and color on the relative size of the opportunities within the infrastructure space, I think in your prepared remarks you mentioned airports as well as research? Thanks.

I believe it's too early to provide specific numbers. However, in the realm of research, we're making advancements that enhance safety, health, and efficiency through IT, engineering, and science, which many may overlook. For example, we manage the National Cancer Lab for the National Cancer Institute as part of Health and Human Services, as well as the National Energy Lab in Pittsburgh for the Department of Energy. These programs focus on early-stage research and development. We anticipate that the current administration will invest significantly in renewable energy. The focus and activities at the National Energy Technology Lab are expected to expand, particularly in areas like wind, solar, and hydro. Additionally, we collaborate with the Defense Threat Reduction Agency and engage in various projects for the Army in Fort Detrick within the medical field. Although we don't often discuss this work, partly because it lacks major contracts like the Navy NextGen project, our commitment to early-stage scientific research remains strong. As is well known, we were established as a science application company, and we continue to have a substantial presence in this area.

I appreciate that. Thank you.

Yes.

Thanks, Tobey.

Oh thanks. Good morning.

Hi, good morning.

Good morning. Roger, just on the SDA business, I think the expectation when you all bought it was that, it would be about $500 million of sales and grow at 10%, it looks like you're running about $300 million now. Where do you expect that run rate to be by the end of this year? And then what are you all looking for on the infrastructure side to kind of give you clarity on what incremental opportunity that could provide for that business?

We do not provide guidance on a detailed level, nor by segment or program, and we won’t start now. The SDA business has certainly been impacted by COVID, leading to decreased airport traffic, which in turn has affected our operations, particularly overseas where funding depends on ticket surcharges. Consequently, we anticipate falling short of our initial business projections for this year following our acquisition of the L3 business. However, in the U.S., we are still witnessing robust activity from TSA and Customs and Border Patrol for equipment purchases, since in this market, funding is linked to the Federal budget rather than volume. As I mentioned earlier, we received an award for VACIS and another for rail at the border. We are currently bidding on enhancements for CT technology at major airport checkpoints, and we have a prototype being demonstrated at Dallas. Visitors departing from Dallas Airport will see our CT scanner in use. We also expect some infrastructure funding from the Stimulus Bill to be allocated for ports and borders, with possibly some going toward airports, and we're actively pursuing those opportunities. Different countries are experiencing varying impacts; while some are struggling, new opportunities have emerged that were not originally anticipated. It's a mixed scenario overall. I want to emphasize that the pandemic has indeed impacted the SDA business, and we now believe it will take until late 2022 or early 2023 before we return to normal volume levels, which was not the trajectory we previously expected for the end of this year or early next year.

That's helpful. And then Jim, a lot of focus on cash flow obviously last quarter. I'm wondering if you could just provide some perspective on the updated guidance for this year of $875 million, is that a level of operating cash that you can grow off of in 2022? If not, what are some of the headwinds you face there? Thank you.

Yes, absolutely. The change in the guide is really as I said in the prepared remarks, the result of the expected cash coming in from the MSA settlement. We clearly believe that we should be moving back toward a conversion rate of about 100%. The headwinds for this year really are the reversal of all the tailwinds we had last year. And going forward into '22 the only real change in conversion would be because of significant growth that will require the funding of working capital for receivables and you know, think of that as being roughly, the net amount of that, net of payables is about 27 days of sales is kind of the net working capital metric that we model based on.

Okay it would be that working capital plus the payroll tax, those would be the two primary headwinds in '22?

Yes, that is right.

Okay, thank you very much.

Sure.

Thanks very much and good morning and congratulations Jim. I just wanted to ask about the Civil segment and so, if we back out the legal settlement there, the profitability was a little bit lower than what we're used to seeing, and sort of what drove that and you expected to kind of move back into that sort of low double-digit range in Q2 that we saw last year?

Yes, historically the Civil segment has had a little bit more volatility in its operating income margin number, primarily as a result of the timing of delivery of product out of the security products business and this year will be no exception to that. We have some orders that are in the pipe that are being built, probably you will see those ship in the second half of the year, and you can probably see volatility on the other end for that, that's what our forecast is telling us.

Okay, I will just stick to one. Thanks very much.

All right. Thank you, Seth.

Good morning everyone and congratulations to Jim and Chris.

Thank you very much.

Good morning, Mariana.

So, my question is about SD&A. Yesterday, it was announced that they expect awards from the TSA to expand the deployment of checked baggage screening equipment to all federally managed airports nationwide. Can you please describe what was minor or limited about that contract and also discuss the competitive dynamics in that business?

Yes, Mariana, that's a great question. We did not bid on the contracts you mentioned, which are for the maintenance of checked baggage screening machines. Instead, we decided to focus on bidding for the larger contract that involves all types of checkpoint equipment, including screening machines, scanners, and trace detection equipment. We were concerned that trying to bid on both could jeopardize our chances of securing the larger contract we are aiming for, and you should hear more about it sometime this month.

And how is competitive dynamics there for the main competitors and how has that over the last year?

Well, we currently hold what I think is the largest contract for the maintenance of the checkpoint screening equipment and while the TSA has divided that up, we have consistently gotten good performance ratings and we think that we're well positioned to win a big piece of that work later this month.

Thanks, good morning. I wanted to see if you could provide an update on dynamics. It looks like the revenue run rate there just based on disclosure around the acquired revenue was a little bit lower, is that just seasonality? And then anything you can say with regard to the lunar-lander and the protest there? Thanks.

Well see, I'll start off and let Jim kind of catch you up on numbers. First of all on the Dynetics integration, the team is going really well. You know their growth on a standalone basis is really eye-watering. And we've integrated our Leidos Innovation Center into Dynetics to better cross-fertilize our technology with their technology and that has really created a lot of excitement and we will see dividends of that in quarters to come. But performance at Dynetics is really solid and they continue to win programs in their relevant area and our hypersonic glide body facility is up and running. I was down there two weeks ago, three weeks ago, it's going classified. We actually have parts that we're building and really across the board Dynetics is going well. I will give you a little bit of insight on HLS. I can't give you much. So there were three bidders two of which everybody in the country knows and us, and the contract was given to SpaceX and upon our debrief and our review we felt that things needed a closer look, and so we did file a protest, and I'm not going to disclose a lot of what's in our protest. There is some stuff out on the web. There was a good article written out of the Washington Post that I would refer you to and I would also caution that the Washington Post is owned by one of the companies that was a competitor, but I still thought that the article was very thoughtful and is a good basis of trying to understand what's going on in the HLS program. And because our protest is really sort of and it's not quite a lawsuit, but it is certainly a dispute with a customer, I'd just rather not comment at length on our protest, but they typically last about 99 days and so in a couple months we will see what comes out of the HLS program.

Yes, in terms of the numbers, our policy is not to include pro forma pre-acquisition revenues when calculating our growth rate. Therefore, we did not account for the strong growth that Dynetics experienced on its own last year in our growth figures. Now that we have owned it for a year, we are including it, and we anticipate further growth as it is integrated into the Defense Solutions segment into 2022 and 2023.

Hey Jim, I think the question may be around, you know we break it out in page 14 of our calculation in the back, but after 12 months we break it off and so what you're seeing, the $83 million number, yes, the $83, that's a sub-period. So you shouldn’t, you should not think of that as being the Q1 revenue from Dynetics. And so I think Dave, what you might be seeing is just a partial period there and it might be misleading here to think that the revenue is down in Dynetics when in fact Dynetics is still continuing to perform well.

Yes, it closed at the end of January a year ago, so that's…

Yes, I was just comparing $83 million for one month versus kind of what you had been your $300 million quarterly run rate the last couple of quarters.

Yes, I think that's just a little, it's just a timing thing, yes for sure.

All right, thanks very much.

Yes, okay thanks.

Great, thank you Rob, and thank you all for your time this morning and for your interest in Leidos. We look forward to updating you again soon. Have a great day.